Contribution of BAP1 loss and p16 (CDKN2A) deletion analysis to the definitive diagnosis of mesothelioma in effusion cytology

被引:0
|
作者
Aydogdu, G. [1 ]
Ozekinci, S. [1 ]
机构
[1] Dicle Univ, Fac Med, Dept Pathol, Diyarbakir, Turkiye
关键词
Mesothelioma; immunohistochemistry; BAP1; FISH; MALIGNANT MESOTHELIOMA; HOMOZYGOUS DELETION; FISH; GENE;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: The cytological diagnosis of mesothelioma is a controversial is-sue, and definitive diagnosis often requires ancillary tests. The aim of this study was to investigate the contribution of BRCA1-associated protein (1) (BAP1) loss and p16 (CDKN2A) homozygous deletion (HD) on the early diagnosis of mesothelioma in effusion fluids. MATERIALS AND METHODS: Between 2019-2022, 21 pleural and peritoneal fluid samples di-agnosed with atypical mesothelial proliferation in our institution were included in the study. The slides of the cases that underwent BAP1 immu-nohistochemistry (IHC) were retrieved from the archive and re-examined. Homozygous deletion (HD) of p16 (CDKN2A) was investigated by the fluorescence in situ hybridization (FISH) method in cell blocks of cytology samples. At least 100 atypical mesothelial cells were counted in each case, and the HD threshold value was >10%. RESULTS: The mean age of the cases was 63.47 years (34-90 years), female/male ratio was 3/1. Of the pleural mesothelioma cases, 16 were epithelioid, 2 were biphasic, and 1 were sarco-matoid. Two cases were diagnosed with perito-neal well-differentiated papillary mesothelioma (WDPM). BAP1 loss was observed in 11 (69%) of 16 cases. HD deletion of p16 (CDKN2A) was seen in 11 (58%) patients with FISH. The HD threshold value was 10-20% in 6 of the cases, 30-50% in 3 cases, and above 90% in 2 cases. While HD de-letion was observed in p16 (CDKN2A) in all bi-phasic and sarcomatoid cases (n=3), no deletion was observed in peritoneal WDPM (n=2). Positiv-ity was observed with at least one method in 12 (86%) of 14 pleural mesotheliomas who under-went both BAP1 IHC and p16 (CDKN2A) FISH. Due to technical reasons, the FISH signal could not be obtained in two cell blocks, so no results could be obtained. CONCLUSIONS: Asbestos exposure in ar-eas where mesothelioma is endemic and/or the presence of proliferating mesothelial cells in cy-tological examination are important clues for diagnosis. In controversial cases, BAP1 IHC should be the first step in an ancillary test. Al-though the FISH method applied to cell blocks has cytology-specific limitations and difficul-ties, investigating the p16 (CDKN2A) deletion with FISH in selected cases will contribute to the diagnosis.
引用
收藏
页码:10001 / 10007
页数:7
相关论文
共 50 条
  • [1] Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology Specimens
    Hwang, Harry C.
    Sheffield, Brandon S.
    Rodriguez, Stephanie
    Thompson, Kim
    Tse, Christopher H.
    Gown, Allen M.
    Churg, Andrew
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2016, 40 (01) : 120 - 126
  • [2] Investigation of MTAP and BAP1 staining loss and P16/CDKN2A deletion in pleural cytology specimens and its role in the diagnosis of mesothelioma
    Seker, Nazli Sena
    Tekin, Emel
    Ak, Guntulu
    Metintas, Muzaffer
    Metintas, Selma
    Dundar, Emine
    DIAGNOSTIC CYTOPATHOLOGY, 2024, 52 (04) : 211 - 216
  • [3] Role of p16 deletion and BAP1 loss in the diagnosis of malignant mesothelioma
    Liu, Jing
    Liao, Xuanzhi
    Gu, Yingying
    Fu, Lin
    Zhao, Jin
    Li, Longguang
    Chen, Zhucheng
    Jiang, Juhong
    JOURNAL OF THORACIC DISEASE, 2018, 10 (09) : 5522 - 5530
  • [4] BAP1 Immunostain and CDKN2A (p16) FISH Analysis Clinical Applicability for the Diagnosis of Malignant Mesothelioma in Effusions
    Walts, Ann E.
    Hiroshima, Kenzo
    McGregor, Stephanie M.
    Wu, Di
    Husain, Aliya N.
    Marchevsky, Alberto M.
    DIAGNOSTIC CYTOPATHOLOGY, 2016, 44 (07) : 599 - 606
  • [5] Usefulness of p16/CDKN2A fluorescence in situ hybridization and BAP1 immunohistochemistry for the diagnosis of biphasic mesothelioma
    Wu, Di
    Hiroshima, Kenzo
    Yusa, Toshikazu
    Ozaki, Daisuke
    Koh, Eitetsu
    Sekine, Yasuo
    Matsumoto, Shinji
    Nabeshima, Kazuki
    Sato, Ayuko
    Tsujimura, Tohru
    Yamakawa, Hisami
    Tada, Yuji
    Shimada, Hideaki
    Tagawa, Masatoshi
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2017, 26 : 31 - 37
  • [6] FISH Analysis of p16 and BAP1 Immunohistochemistry for the Diagnosis of Mesothelioma
    Hiroshima, K.
    Wu, D.
    Yusa, T.
    Ozaki, D.
    Koh, E.
    Sekine, Y.
    Haba, R.
    Washimi, K.
    Nabeshima, K.
    Tsujimura, T.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2157 - S2158
  • [7] BAP1 Immunocytochemistry and BAP1 and p16 Fluorescence In-Situ Hybridization for the Diagnosis of Malignant Mesothelioma in Effusion Samples
    Agrawal, Tanupriya
    Fetsch, Patricia
    Abdullaev, Zied
    Skarshaug, Shannon
    Zgonc, Valerie
    Roth, Mark
    Pack, Svetlana D.
    Hassan, Raffit
    Filie, Armando
    MODERN PATHOLOGY, 2018, 31 : 129 - 129
  • [8] BAP1 Immunocytochemistry and BAP1 and p16 Fluorescence In-Situ Hybridization for the Diagnosis of Malignant Mesothelioma in Effusion Samples
    Agrawal, Tanupriya
    Fetsch, Patricia
    Abdullaev, Zied
    Skarshaug, Shannon
    Zgonc, Valerie
    Roth, Mark
    Pack, Svetlana D.
    Hassan, Raffit
    Filie, Armando
    LABORATORY INVESTIGATION, 2018, 98 : 129 - 129
  • [9] Comparison of MTAP immunohistochemistry (IHC) with p16/CDKN2A deletions/loss and utility of MTAP and BAP1 IHC in the diagnosis of malignant pleural mesothelioma (MPM)
    Shahi, Maryam
    Eguchi, Takashi
    Zauderer, Marjorie
    Travis, William
    Jungbluth, Achim
    Frosina, Denise
    Fayad, Miriam
    Asher, Marina
    Adusumilli, Prasad S.
    Ladanyi, Marc
    Sauter, Jennifer L.
    LABORATORY INVESTIGATION, 2018, 98 : 750 - 751
  • [10] Comparison of MTAP immunohistochemistry (IHC) with p16/CDKN2A deletions/loss and utility of MTAP and BAP1 IHC in the diagnosis of malignant pleural mesothelioma (MPM)
    Shahi, Maryam
    Eguchi, Takashi
    Zauderer, Marjorie
    Travis, William
    Jungbluth, Achim
    Frosina, Denise
    Fayad, Miriam
    Asher, Marina
    Adusumilli, Prasad S.
    Ladanyi, Marc
    Sauter, Jennifer L.
    MODERN PATHOLOGY, 2018, 31 : 750 - 751